Trial Profile
Clinical Trials Insight: 700015338
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2009
Price :
$35
*
At a glance
- Drugs Raseglurant (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Sponsors Addex Therapeutics
- 08 Aug 2009 Results reported in Gut.
- 08 Aug 2009 Primary endpoint 'Time with oesophageal pH less than 4' has been met.
- 19 Apr 2007 Status change